Thomas J. Lynch Jr, MD, Leaves Yale Cancer Center

Get Permission

Thomas J. Lynch Jr, MD

Thomas J. Lynch Jr, MD, Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital at Yale-New Haven, left Yale in August to become Chairman and Chief Executive Officer of the Massachusetts General Physicians Organization.

Dr. Lynch joined Yale Cancer Center as Director in 2009 and assumed the role of inaugural Physician-in-Chief at Smilow, which opened that year. Under his leadership, more than 130 scientists and clinicians joined the institutions, new patient volume grew from 3,500 to 9,000 through key affiliations, and participation in therapeutic clinical trials grew by 325%.

  Peter Schulam, MD, PhD, Professor of Urology and Chair/Chief of Yale’s Department of Urology, will serve as the interim Director of Yale Cancer Center and Physician-in-Chief at Smilow.

Dr. Schulam joined in 2012 as inaugural Chief of the Department of Urology at Yale-New Haven Hospital and Chair of the Department at Yale School of Medicine, where he has established a multidisciplinary team in urologic oncology. He has implemented a program for MRI-fusion–guided biopsy of prostate cancer, and leads a research program focused on prostate cancer imaging. In addition, Dr. Schulam. ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.